Melgious Jin Yan Ang

The Modular CAR: Adapting T Cells without Reengineering Them

Abstract The therapeutic potential of chimeric antigen receptor (CAR) T cells has long been limited by the static nature of the engineered receptor; once manufactured, the cell is committed to a single antigen, unable to respond to the immune evasion and antigen heterogeneity tha...